Literature DB >> 18057536

Association of Interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo.

Abdullah Abanmi1, Fahad Al Harthi, Abdulrahman Zouman, Aida Kudwah, Mohammed Al Jamal, Misbahul Arfin, Mohammad Tariq.   

Abstract

The promoter region of human Interleukin -10 gene is highly polymorphic and has been associated with numerous autoimmune diseases. Recent studies have linked vitiligo with defective autoimmune system. This study is aimed to explore a possible association between IL-10 gene polymorphism and vitiligo in Saudi population. This case control study consisted of 184 Saudi subjects including 83 vitiligo patients (40 males, 43 females mean age 27.85 +/- 12.43 years) and 101 matched controls. Genomic DNA was extracted from the blood samples of healthy controls and Vitiligo patients visiting out patient clinic of Department of Dermatology, Riyadh Armed Forces Hospital, using QIA ampR DNA mini kit (Qiagen CA, USA). Interleukin-10 gene was amplified by polymerase chain reaction (PCR) using Arms primers to detect any polymorphism involved at positions -592, -819 and -1082. The frequencies of GG genotype at -1082, and CC genotype at positions -592 and 819 were significantly higher in vitiligo patients compared to healthy subjects suggesting that GG and CC genotypes might be susceptible to vitiligo in Saudis. On the other hand genotypes -1082 GA, -819 CT, and -592 CA of IL-10 were more prevalent in healthy controls suggesting protective effects of GA, CT and CA genotypes against vitiligo. This study indicates that the IL-10 gene may play a significant role in the etiology of vitiligo among Saudis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18057536      PMCID: PMC3850539          DOI: 10.1155/2008/210609

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  13 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Association of Interleukin-10 promotor polymorphisms with atrial fibrillation in Han Chinese.

Authors:  Dong-Dong Zheng; Shun-Nian Ji; Chu Chen; Xin-Tao Deng; Ya-Min Su; Hai-Yan Pan; Xing-Xing Cai; Xiao-Fei Li; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Authors:  Stanca A Birlea; Ying Jin; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanja van Geel; Jo Lambert; Andreas Overbeck; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

4.  Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese.

Authors:  Gui-Liang Shi; Xing-Xing Cai; Ya-Min Su; Chu Chen; Xin-Tao Deng; Hai-Yan Pan; Meng-Kan Fan; Jian-Hua Zhu; Min Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 5.  The Role of the NKG2D in Vitiligo.

Authors:  Lourdes Plaza-Rojas; José A Guevara-Patiño
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

6.  Transporter TAP1-637G and immunoproteasome PSMB9-60H variants influence the risk of developing vitiligo in the Saudi population.

Authors:  Nasser Attia Elhawary; Neda Bogari; Essam Hussien Jiffri; Mona Rashad; Abdulhamid Fatani; Mohammed Tayeb
Journal:  Dis Markers       Date:  2014-12-07       Impact factor: 3.434

7.  Characterization of human bone morphogenetic protein gene variants for possible roles in congenital heart disease.

Authors:  Fei-Feng Li; Xia Deng; Jing Zhou; Peng Yan; Er-Ying Zhao; Shu-Lin Liu
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

8.  Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  BMC Genomics       Date:  2017-01-28       Impact factor: 3.969

9.  Protective effects of Xinji'erkang on myocardial infarction induced cardiac injury in mice.

Authors:  Juan Hu; Yong-Xue Zhang; Li Wang; Ling Ding; Guang-Yao Huang; Guo-Wei Cai; Shan Gao
Journal:  BMC Complement Altern Med       Date:  2017-06-26       Impact factor: 3.659

10.  HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.

Authors:  Qian Zhang; Tingting Cui; Yuqian Chang; Weigang Zhang; Shuli Li; Yuanmin He; Bing Li; Ling Liu; Gang Wang; Tianwen Gao; Chunying Li; Zhe Jian
Journal:  J Cell Mol Med       Date:  2018-07-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.